SurgePays (NASDAQ:SURG) Stock Passes Above Two Hundred Day Moving Average - What's Next?

SurgePays, Inc. (NASDAQ:SURG - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.65 and traded as high as $2.99. SurgePays shares last traded at $2.93, with a volume of 54,928 shares.

Analyst Ratings Changes

SURG has been the subject of several recent research reports. Wall Street Zen raised SurgePays from a "sell" rating to a "hold" rating in a report on Saturday, August 30th. Ascendiant Capital Markets raised their target price on shares of SurgePays from $8.75 to $9.00 and gave the stock a "buy" rating in a research note on Monday, June 16th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, SurgePays currently has a consensus rating of "Buy" and an average price target of $9.00.

SurgePays Trading Down 1.0%

The company has a quick ratio of 0.84, a current ratio of 1.11 and a debt-to-equity ratio of 101.87. The business has a fifty day simple moving average of $2.76 and a 200 day simple moving average of $2.65. The company has a market cap of $59.86 million, a price-to-earnings ratio of -1.18 and a beta of 0.43.

SurgePays (NASDAQ:SURG - Get Free Report) last released its earnings results on Wednesday, August 13th. The medical equipment provider reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.31) by ($0.05). SurgePays had a negative net margin of 133.85% and a negative return on equity of 333.87%. The business had revenue of $11.52 million during the quarter, compared to analyst estimates of $16.14 million. SurgePays has set its FY 2025 guidance at EPS. On average, equities analysts anticipate that SurgePays, Inc. will post -1.66 EPS for the current fiscal year.

Institutional Investors Weigh In On SurgePays

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. James Investment Research Inc. lifted its position in shares of SurgePays by 46.2% during the 2nd quarter. James Investment Research Inc. now owns 19,000 shares of the medical equipment provider's stock valued at $59,000 after acquiring an additional 6,000 shares during the period. NewEdge Advisors LLC raised its holdings in SurgePays by 46.2% during the second quarter. NewEdge Advisors LLC now owns 19,000 shares of the medical equipment provider's stock worth $59,000 after purchasing an additional 6,000 shares during the last quarter. D.A. Davidson & CO. acquired a new position in SurgePays during the first quarter worth $25,000. Jane Street Group LLC acquired a new position in shares of SurgePays during the 2nd quarter worth $42,000. Finally, Goldman Sachs Group Inc. acquired a new position in shares of SurgePays during the 1st quarter worth $28,000. 6.94% of the stock is currently owned by institutional investors and hedge funds.

SurgePays Company Profile

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.